Location: The Newseum, Knight Broadcast Studio- 555 Pennsylvania Avenue, NW, Washington, DC
Tuesday | February 28, 2017 | 8:00 AM- 10:30 AM
Innovations in medical research and technology have produced cures and breakthrough therapies to overcome diseases that were once considered a death sentence. Polio is preventable with a vaccine, HIV is managed with a daily drug regimen, and Hepatitis C now has a cure.
But are these breakthroughs reaching all communities? How can we balance the high costs of drug development with affordability? And what can we do to ensure that new cures continue to be developed?
Following the passage of the long-awaited 21st Century Cures legislation, and at the start of a new Congress and new administration, join The Hill for a conversation with policymakers, health officials, industry representatives and patient advocates on the value of cures - their implications for society's health and public expenditures, and the path forward.
Rep. Diana DeGette (D-CO);
Member, House Committee on Energy and Commerce
Rep. Fed Upton (R-MI);
Former Chairman, House Committee on Energy and Commerce
Executive Vice President, Corporate and Medical Affairs, Gilead
Georges Benjamin, MD;
Executive Director, American Public Health Association
Douglas Dieterich, MD,
Director, Institute for Liver Medicine, Professor of Medicine, Division of Liver Diseases, Mount Sinai Health Systems
Dana Goldman, PhD;
Leonard D. Schaeffer Chair and Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
Garth Graham, MD;
President, Aetna Foundation
President, Fuerza Contra Alzheimer's
Timothy Wright, MD;
Chief R&D Officer, Regulus Therapeutics
Join the conversation by following @TheHillEvents and @SchaefferCenter
and using: #ValueofaCure